The process by which proteins are made, translation, is based on the ‘reading’ of mRNA that was produced via the process of transcription. Any changes to the DNA that encodes a gene will lead to an alteration of the mRNA produced. In turn, the altered mRNA may lead to the production of a protein that no longer functions properly. Even changing a single nucleotide along the DNA of a gene may lead to a completely non functional protein.
Point Mutations
Genetic alterations can be placed into two general categories. The first category is comprised of changes that alter only one or a few nucleotides along a DNA strand. These types of changes are termed point mutations.
When ribosomes read a messenger RNA molecule, every three nucleotides is interpreted as one amino acid. These three letter codes are called codons. To make an analogy to an English sentence: ‘The fat cat ate the rat’ would contain 6 codons. The changes caused by mutation can lead to things like ‘The fat bat ate the rat.’ or ‘The fa’ or ‘The fat oca tat her at...’ The impact on the protein depends on where the change occurs and the kind of change.
The three-letter codons read by ribosomes may be changed by mutation in one of three ways:
Nonsense mutations
The new codon causes the protein to prematurely terminate, producing a protein that is shortened and often does not function properly or at all.

Missense mutations
The new codon causes an incorrect amino acid to be inserted into the protein. The effects on the function of the protein depend on what is inserted in place of the normal amino acid.

Frameshift mutations
The loss or gain of 1 or 2 nucleotides causes the affected codon and all of the codons that follow to be misread. This leads to a very different and often non-functional protein product.

Transcription Errors
Some DNA damage results in a modified nucleotide or small group of nucleotides that cannot be ‘read’ by RNA polymerase. When the RNA polymerase complex reaches these spots they will sometimes bypass the damage by adding in nucleotides in an effort to continue going, even if it means putting in the wrong thing. This process is known as transcriptional mutagenesis and it may play a significant role in the development of cancer.
Translocations
Another category of mutations involves alterations of larger amounts of DNA, often at the level of the chromosome. These are called translocations and involve the breakage and movement of chromosome fragments. Often, breaks in two different chromosomes allow for the formation of two ‘new’ chromosomes, with new combinations of genes.
While it might appear that this would not cause much trouble, since all the genes are still present, the process can lead to deregulated cell growth in a number of ways
1. The genes may not be transcribed and translated appropriately in their new location.
2. The movement of a gene can lead to an increase or a decrease in its level of transcription.
3. The breakage and re-joining may also occur within a gene, leading to its inactivation.
For some cancers, particular translocations are very common and may even be used in diagnosing the disease. Translocations are common in leukemias and lymphomas and have been less commonly identified in cancers of solid tissues. An example would be an exchange between chromosomes 9 and 22 seen in over 90% of patients with chronic myelogenous leukemia (CML). The exchange leads to the formation of a shortened form of chromosome 22 called the Philadelphia chromosome (after the location of its discovery). This translocation leads to the formation of an oncogene from the abl proto-oncogene.
Other cancers that are often (or always) associated with particular translocations include Burkitt’s lymphoma, B-cell lymphomas and several types of leukemia.